A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Status:
Terminated

Trial end date:
2020-05-01

Target enrollment:

Participant gender:

This study will assess the long-term safety and tolerability of ALKS 5461 as an adjunctive treatment for refractory MDD.

Phase 3

Alkermes, Inc.